Duchenne Muscular Dystrophy Patient Recruitment in Delaware

TheraNovex connects clinical trial sponsors with pre-screened, eligible Duchenne Muscular Dystrophy patients across Delaware, including Wilmington, Dover, Newark, and beyond.

DMD patient recruitment for exon-skipping, gene therapy, and corticosteroid clinical trials.

Who qualifies: Males aged 4–18 with confirmed DMD (dystrophin mutation), ambulatory and non-ambulatory.

Recruitment challenges: Dystrophin mutation confirmation and ambulatory status requirements.

Our approach: Neuromuscular disease center networks, Parent Project Muscular Dystrophy partnerships.

Our recruitment network spans all major metropolitan areas in Delaware, ensuring broad geographic coverage for your Duchenne Muscular Dystrophy trial.